Microlissencephaly

Microlissencephaly is an extremely rare congenital brain malformation characterized by the combination of severe microcephaly (abnormally small head) and lissencephaly (smooth brain surface due to absent or reduced normal cortical folding). This condition reflects a profound disturbance in both brain growth and neuronal migration during early fetal development. The cerebral cortex, which normally develops complex folds (gyri) and grooves (sulci), remains abnormally smooth and markedly reduced in size. Microlissencephaly is sometimes referred to as microcephaly with simplified gyral pattern when the cortex shows some rudimentary folding, though the most severe forms show near-complete agyria (absence of gyri). The condition primarily affects the central nervous system, with devastating neurological consequences. Key clinical features include extreme microcephaly (head circumference typically more than 3 standard deviations below the mean at birth), severe intellectual disability, profound developmental delay, intractable epilepsy (seizures that are difficult to control), spasticity, and feeding difficulties. Many affected infants also exhibit failure to thrive and may have associated congenital anomalies depending on the underlying genetic cause. Several subtypes have been described, including Norman-Roberts syndrome and Barth microlissencephaly type, each associated with distinct genetic etiologies. Mutations in genes such as NDE1, KATNB1, and RELN, among others, have been implicated in various forms of microlissencephaly. There is currently no cure or disease-modifying treatment for microlissencephaly. Management is entirely supportive and symptomatic, focusing on seizure control with antiepileptic medications, nutritional support (which may require gastrostomy tube placement), physical therapy to address spasticity and motor impairment, and management of respiratory complications. The prognosis is generally poor, with many affected individuals experiencing significant morbidity and shortened life expectancy, particularly in the most severe forms. Early involvement of a multidisciplinary team including neurologists, geneticists, and developmental specialists is essential for optimizing care.

Common questions about Microlissencephaly